← Open Payments lookup

CHAD WHYTE: Open Payments

NPI 1427222959 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$96,723 in 309 payments from 30 companies in 2025. Trend: 2023 $88,776 · 2024 $48,432 · 2025 $96,723

Speaker / faculty: $53,325Honoraria: $35,152Food & beverage: $4,752Consulting: $2,525Travel & lodging: $968
CompanyPaymentsAmount
ABBVIE INC.71$44,928
Axsome Therapeutics, Inc.34$25,726
Lundbeck LLC30$12,557
PFIZER INC.23$11,266
Teva Pharmaceuticals USA, Inc.34$324
Novartis Pharmaceuticals Corporation20$262
UCB, Inc.29$248
Neurocrine BioSciences, Inc.13$193
Merz Pharmaceuticals, LLC8$147
ARGENX US, INC.5$129

Products named: QULIPTA, Symbravo, VYEPTI, NURTEC ODT, UBRELVY, AUSTEDO XR, KESIMPTA, INGREZZA.

Industry payments across NE — which companies pay providers there.